Nexalin Seeks Shareholder Approval to Lift Alumni Capital Equity-Line Cap
NXL is trading near its 52-week low of $1.59 (8.2% above the low).
Summary
Nexalin is asking shareholders on December 4, 2026 to approve issuing more than 20% of its stock to Alumni Capital under its $15 million equity line. Without the vote it can raise only about $98,036 of that facility, while approval would be heavily dilutive at current prices.
Key Events · Financing and Capital Events · NXL
-
Special Meeting Set for December 4
Shareholders of record on October 30, 2026 will vote on issuing AMPA shares to Alumni Capital in excess of the Nasdaq 20% Exchange Cap, along with a proposal to adjourn for more proxies.
-
Exchange Cap Limits Raise to $98,036
The Exchange Cap is 149,750 shares (20% of 748,754 outstanding at signing). With 100,732 Commitment Shares already issued, only 49,018 AMPA shares remain — about $98,036 at an assumed $2.00, versus the $15,000,000 Investment Amount.
-
Dilution Tables Show 86.71%-92.88%
At $2.00 the full $15 million equals 7,500,000 shares (86.71% of post-issuance outstanding); at $1.50, 10,000,000 shares (89.69%); at $1.00, 15,000,000 shares (92.88%). Purchase prices are 92% or 97% of market at each sale.
-
Nasdaq Equity Deadline January 4, 2027
A Nasdaq Hearings Panel granted continued listing on September 25, 2026 on condition the company shows $2,500,000 of stockholders' equity by January 4, 2027; the proxy says failure to access the facility could hurt meeting that condition and the going-concern status.
Analysis · NXL · Industrial Applications And Services
Nexalin signed the $15 million Alumni Capital purchase agreement on August 19, 2026, but Nasdaq's 20% rule caps what it can issue without a shareholder vote. Without approval, the company could sell only 49,018 more shares — about $98,036 at an assumed $2.00 — against a $15 million facility it is counting on. That matters because Nexalin carries a going-concern warning and must show $2.5 million of stockholders' equity by January 4, 2027 to keep its Nasdaq listing. Approval unlocks the capital but at a steep cost: at $2.00 a share, the full $15 million would be 7,500,000 shares, or 86.71% of the post-issuance count, and at $1.00 it would be 15,000,000 shares, or 92.88%. Because the purchase price is set at a 92% or 97% discount to market at each sale, a falling stock price means more shares for the same dollars.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 38.5% of the 1020 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXL was trading at $1.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $1.59 to $49.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.